Daily FNArena News - Australia

Private hospital operator Healthscope is expected to weather insurer rate reductions, given its margins are among the highest in the sector. Morgan Stanley initiates coverage.

Weekly Update on ASX-listed companies buying in their own stock.

Despite a weak outlook for coal prices, Whitehaven Coal enjoys a relatively better position among coal producers, brokers maintain.

Research from BIS Shrapnel suggests Australian dwelling commencements peaked in 2014-2015 and will gradually decline in coming years.

Weekly update on recommendation, target price, and earnings forecast changes.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

Challenger has acquired a UK-based alternatives investment business to expand its distribution network in Europe.

FNArena’s weekly update on short positions in the Australian share market.

Most brokers expect newly listed Medibank Private to deliver on prospectus forecasts but remain concerned about the outlook for FY16.

Volatility in global markets is taking its toll on investor confidence but broker advice is to be defensive and look to those Australian stocks which benefit from a lower FX rate.